Trial intelligence / Profile preview

Feasibility of Enzymatic Debridement (DGD) in Partial Thickness Burns

NCT00898521Phase 2Completed

Sponsor
MediWound
Start
Dec 2009
Primary completion
Dec 2015
Modality
Replacement Enzymes
Countries
2
01

Overview

A Phase 2 trial of anacaulase-bcdb in Thermal Burn, sponsored by MediWound. Started Dec 2009; status: completed.

02

Drugs

anacaulase-bcdb
03

Conditions

Thermal Burn

Beyond the preview

Go deeper on NCT00898521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00898521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call